As many labs are starting to implement these stem cell models, it is becoming increasingly important to define key experimental variables and address challenges in conducting, reporting, and evaluating in vitro and in vivo studies.
Open article here:
https://www.nature.com/articles/s41586-024-08487-6
Open article here:
https://www.nature.com/articles/s41586-024-08487-6
Comments
A summary of our recommendation can be seen here:
We also point out that to substantiate claims about genetic background in disease models, a large number of independent lines is required as well as orthogonal assays
Depositing raw data in public databases, describing experimental details in papers, and using standardized terms is critical.